Evidence map›Paper›PMID 36767070›Full record

Observational studyInternational journal of environmental research and public health2023

Complications Associated with Peripherally Inserted Central Catheters (PICC) in People Undergoing Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Home Hospitalization.

Ana María Garcés-Carrasco, Enric Santacatalina-Roig, Carlos Carretero-Márquez, Antonio Martínez-Sabater, Evelin Balaguer-López

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ana María Garcés-CarrascoOncology and Hematology Department, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
Enric Santacatalina-RoigOncology and Hematology Department, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
Carlos Carretero-MárquezOncology and Hematology Department, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.
Antonio Martínez-SabaterNursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.ORCID 0000-0002-6440-1431
Evelin Balaguer-LópezNursing Department, Facultat d'Infermeria i Podologia, Universitat de València, 46010 Valencia, Spain.ORCID 0000-0003-4204-3511
Hospital Clínico Universitario de Valencia · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe SARS-CoV-2 pandemic generated the need to keep immunosuppressed patients away from hospital institutions for as long as possible. This in turn stimulated the implementation of a home hospitalization model for autologous hematopoietic stem-cell transplantation (HSCT). PURPOSE: To analyze whether there are significant differences in post-transplantation complications related to catheters observed in patients treated in the home-transplant care modality compared to patients treated in the hospital. METHODOLOGY: Observational, analytical, longitudinal, and retrospective study of cases and controls. A convenience sample was chosen, in which the cases comprised 20 patients included in the home HSCT care model. For each patient, it was considered suitable to propose two controls among those who received autologous transplantation in the last five years with a baseline demographic and pathological profile similar to the case for whom they were control.

resultsThe home patients achieved an average of 22.4 ± 2.6 days of evolution with an average of 16.4 ± 2.08 days post-transplant, compared to the hospital process with an average of 21.21 ± 4.18 days of evolution and 15.51 ± 3.96 days post-transplant (evolution days

conclusionsThe results obtained indicate that regarding the appearance of complications associated with PICCs in home hospitalization HSCT patients, there are no significant differences compared to hospitalization, so that home care can be a safe context for people with these lines.

Indexed as

Catheterization, Central VenousCOVID-19Hematopoietic Stem Cell TransplantationCathetersHospitalizationHumansRetrospective StudiesRisk FactorsSARS-CoV-2Transplantation, Autologousautologouscatheter-related infectionscentral catheter accesshematologyhome nursingtransplantation

Identifiers

PMID36767070
PMCPMC9914549
OpenAlexW4317107961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.